spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  IVAX Corporation 

 HSMN NewsFeed - 28 Sep 2010
Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2010
Teva Announces the Appointment of Dr. Philip Frost as Chairman of Its Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 28 Jan 2010
Abraxis BioScience Confirms Plan to Spin-off Abraxis Health in 2010 and Announces Management Structure
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2008
Medical Ventures to Acquire Two Vascular Device Developers
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 3 Jan 2008
IVAX Diagnostics Announces Resignation of President and Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 3 Jan 2008
Noven Announces Changes to Board of Directors and Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2007
Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Sep 2007
IVAX Diagnostics Appoints Kevin D. Clark Chief Operating Officer
Diagnostics Personnel
 HSMN NewsFeed - 22 May 2007
Zila Appoints David R. Bethune as Chairman of Board of Directors
Diagnostics Oncology Personnel
 HSMN NewsFeed - 27 Mar 2007
Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 30 Jan 2007
Teva Receives Approval for Generic Focalin(TM) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Jan 2007
Teva Files Patent Infringement Complaints Regarding Sertraline Hydrochloride
Biopharmaceuticals Litigation
 HSMN NewsFeed - 19 Jan 2007
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
Biopharmaceuticals Generics Endocrinology
 HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Dec 2006
Depomed Announces Sweeping Interim Victory in Litigation against Ivax
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 13 Dec 2006
Elite Pharmaceuticals Appoints a Prominent Specialty Pharmaceutical Executive, Dr. Veerappan Subramanian, to its Board of Directors and Engages Dr. Subramanian as Strategic Advisor
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 29 Nov 2006
Teva Announces Tentative Approval of Sumatriptan Succinate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Nov 2006
Teva Announces Agreement with Pfizer Regarding Idarubicin, Azithromycin, and Epirubicin
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Nov 2006
Court of Appeals Affirms Teva's Generic Zocor(R) Exclusivity
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Oct 2006
TEVA Announces Planned Retirement of President & CEO in 2007
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2006
Teva Announces OxyContin(R) Litigation Dismissed; Settlement with Purdue Finalized
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2006
Teva Announces Tentative Approval for Generic Risperdal(R) Oral Solution
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Oct 2006
Long-Term Data Demonstrated Significantly Better Patient Adherence to COPAXONE(R) versus Interferons in Multiple Sclerosis Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Oct 2006
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Very Active Multiple Sclerosis Patients Benefited from COPAXONE(R) Treatment Following Short-Term Induction with Mitoxantrone
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Study Showed Significant and Sustained Efficacy Of COPAXONE(R) Alone Following Short-Term Combination Therapy With IV Steroids in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Sep 2006
New Data Confirmed Antibodies to COPAXONE(R) do not Impact Its Established and Sustained Long-Term Efficacy in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Sep 2006
Teva Pharmaceutical Industries Ltd. and Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two Biopharmaceuticals, Based on Protalix's Recombinant Plant Cell Expression Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Aug 2006
Teva Announces Settlement of OxyContin(R) Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 21 Aug 2006
Teva Announces Health Canada Approves AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 21 Aug 2006
First Patient Enrolled in Study to Evaluate Impact of Regular Neutralizing Antibody (NAb) Testing on Multiple Sclerosis Treatment Patterns
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Aug 2006
Teva Announces Launch of Generic Zoloft(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 4 Aug 2006
Teva Announces Final Approval of Venlafaxine HCl Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 Jul 2006
Teva Neuroscience Announces AZILECT(R) Is Now Available in Pharmacies - the First, Once-Daily Treatment for Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Jul 2006
Teva Initiates Phase III Study to Confirm Increased Efficacy of Higher Dose of Glatiramer Acetate for the Treatment of Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Jul 2006
Teva Announces Final Approval of Meloxicam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jul 2006
Teva Announces Tentative Approval of Generic Lotrel(R) Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Jun 2006
Teva Receives FDA Approval for Generic Zoloft(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Jun 2006
Teva Provides Generic Biaxin(R) XL Update
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Jun 2006
Teva Receives First U.S. Approval of Generic Zocor(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Jun 2006
Cipher appoints Vice President of Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2006
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 22 Jun 2006
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL Preliminary Injunction
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Jun 2006
COPAXONE(R) Reduced Relapses By 75 Percent in Both Treatment-Naive Multiple Sclerosis Patients and Those Failing Betaseron(R)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Jun 2006
Teva Receives First FDA Approval for Generic Proscar(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Jun 2006
Teva Announces Tentative Approval of Losartan Potassium & Hydrochlorothiazide Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jun 2006
Nabi Biopharmaceuticals Names Jordan I. Siegel Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2006
COPAXONE(R) Reduced Relapses and Stabilized Disability as Measured by Expanded Disability Status Scale, When Avonex(R) Failed
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 May 2006
Teva Announces Tentative Approval for Generic Cozaar(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 May 2006
Abraxis BioScience Appoints New Officers to Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2006
Teva Announces Tentative Approval of Simvastatin Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 May 2006
Teva Announces Approval of Generic Lexapro(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 May 2006
Long-Term Copaxone(R) Study Showed 92% of Multiple Sclerosis Patients Were Still Walking Unaided After a Mean of 10 Years on Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 May 2006
Teva Announces Approval of Polyethylene Glycol 3350 NF for Oral Solution
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 May 2006
District Court Grants Teva Summary Judgment for Generic Zocor(R) Exclusivity
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 25 Apr 2006
Teva Receives First FDA Approval for Generic Pravachol(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Apr 2006
Teva Provides Update on Generic Pravachol(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Apr 2006
Teva Announces Stay of Approval for Generic Pravachol Lifted
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Apr 2006
District Court Denies Apotex's Request to Block Teva's Introduction of First Generic Pravachol(R) In The U.S.
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 12 Apr 2006
Teva Announces Approval of Mitoxantrone Hydrochloride Injection USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Apr 2006
Teva Announces FDA Determination That Generic Pravachol Exclusivity Has Not Been Triggered
Biopharmaceuticals Generics
 HSMN NewsFeed - 5 Apr 2006
Teva Announces That Higher Dose of Copaxone(R) Showed Increased Efficacy in Multiple Sclerosis (MS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Apr 2006
Teva Announces Approval of Deferoxamine Mesylate for Injection USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Mar 2006
Teva Expands Presence in China
Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2006
Teva Provides Update on Generic Pravachol Exclusivity
Biopharmaceuticals Generics
 HSMN NewsFeed - 8 Mar 2006
AstraZeneca Commences Patent Infringement Litigation Against IVAX
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Mar 2006
Teva Announces Tentative Approval of Topiramate Tablets, 50 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Feb 2006
Teva Announces Tentative Approval of Ondansetron Injection USP
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 16 Feb 2006
Teva Announces Tentative Approval of Rabeprazole Sodium Delayed-Release Tablets
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 13 Feb 2006
Teva Announces Tentative Approval of Adenosine Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 Feb 2006
Teva Comments on Pfizer Press Release Regarding Azithromycin
Biopharmaceuticals FDA Generics Litigation
 HSMN NewsFeed - 27 Jan 2006
Teva Announces Favorable Court Decision Regarding Generic Allegra
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Jan 2006
U.S. Federal Trade Commission Clears Teva/IVAX Merger
Biopharmaceuticals Mergers & Acquisitons
 HSMN NewsFeed - 12 Jan 2006
Teva Announces Tentative Approval of Divalproex Sodium Delayed-Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Jan 2006
Teva and IVAX Announce that FTC Review Process Continues on Track and Merger Closing is Expected Shortly
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Jan 2006
Teva Announces Tentative Approval of Simvastatin Tablets
Biopharmaceuticals Generics FDA
Return to NewsFeed  

 Additional items found! 118

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 118 additional stories matching:
IVAX Corporation
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.